For: | Chackelevicius CM, Gambaro SE, Tiribelli C, Rosso N. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. World J Gastroenterol 2016; 22(41): 9096-9103 [PMID: PMC5107591 DOI: 10.3748/wjg.v22.i41.9096] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i41/9096.htm |
Number | Citing Articles |
1 |
Zheng Luo, Cong Huang, Jilan Chen, Yunhui Chen, Hongya Yang, Qiaofeng Wu, Fating Lu, Tian E. Zhang. Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1323859
|
2 |
Chun-Pyo Hong, Areum Park, Bo-Gie Yang, Chang Ho Yun, Min-Jung Kwak, Gil-Woo Lee, Jung-Hwan Kim, Min Seong Jang, Eun-Jung Lee, Eun-Ji Jeun, Gihoon You, Kwang Soon Kim, Youngwoo Choi, Ji-Hwan Park, Daehee Hwang, Sin-Hyeog Im, Jihyun F. Kim, Yoon-Keun Kim, Ju-Young Seoh, Charles D. Surh, You-Me Kim, Myoung Ho Jang. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice. Gastroenterology 2017; 152(8): 1998 doi: 10.1053/j.gastro.2017.02.016
|
3 |
Denis Nchang Che, Jae Young Shin, Hyun Ju Kang, Byoung Ok Cho, Ji Hyeon Park, Feng Wang, Suping Hao, Jae Suk Sim, Dong Jun Sim, Seon Il Jang. Ameliorative effects of Cirsium japonicum extract and main component cirsimaritin in mice model of high‐fat diet‐induced metabolic dysfunction‐associated fatty liver disease. Food Science & Nutrition 2021; 9(11): 6060 doi: 10.1002/fsn3.2548
|
4 |
Changyan Zi, Die Wang, Yongxiang Gao, Lisha He. The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1104943
|
5 |
Paolo Gisondi, Francesco Bellinato, Manfredo Bruni, Giulia De Angelis, Giampiero Girolomoni. Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome. Dermatologic Therapy 2020; 33(6) doi: 10.1111/dth.14281
|
6 |
Haiyan Zhou, Liwen Wang, Feng Liu. Immunological Impact of Intestinal T Cells on Metabolic Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.639902
|
7 |
Z. Yao, G. Liang, Z. L. Lv, L. C. Lan, F. L. Zhu, Q. Tang, L. Huang, X. Q. Chen, M. X. Yang, Q. W. Shan. Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-β. Bulletin of Experimental Biology and Medicine 2021; 171(5): 638 doi: 10.1007/s10517-021-05285-2
|
8 |
Hua Zhang, Yongyuan Ma, Xinying Cheng, Dongbo Wu, Xingming Huang, Bin Chen, Yafeng Ren, Wei Jiang, Xiaoqiang Tang, Ting Bai, Yutian Chen, Yilin Zhao, Chunxue Zhang, Xia Xiao, Jing Liu, Yue Deng, Tinghong Ye, Lu Chen, Han-Min Liu, Scott L. Friedman, Liping Chen, Bi-Sen Ding, Zhongwei Cao. Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine 2021; 13(614) doi: 10.1126/scitranslmed.abd1206
|
9 |
Kristine Griffett, Matthew E. Hayes, Michael P. Boeckman, Thomas P. Burris. The role of REV-ERB in NASH. Acta Pharmacologica Sinica 2022; 43(5): 1133 doi: 10.1038/s41401-022-00883-w
|
10 |
Audrey Beringer, Pierre Miossec. Systemic effects of IL-17 in inflammatory arthritis. Nature Reviews Rheumatology 2019; 15(8): 491 doi: 10.1038/s41584-019-0243-5
|
11 |
Gabriel P. Bacil, Bruno Cogliati, Daniel R. Cardoso, Luís Fernando Barbisan, Guilherme R. Romualdo. Are isothiocyanates and polyphenols from Brassicaceae vegetables emerging as preventive/therapeutic strategies for NAFLD? The landscape of recent preclinical findings. Food & Function 2022; 13(16): 8348 doi: 10.1039/D2FO01488B
|
12 |
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494
|
13 |
Zheng Luo, Lu-Yun Xia, Yu-Qin Tang, Lili Huang, Dan Liu, Wen-Ying Huai, Chun-Jiang Zhang, Yan-Qiu Wang, Yong-Mei Xie, Qiao-Zhi Yin, Yun-Hui Chen, Tian-E. Zhang, Robson Xavier Faria. Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1670014
|
14 |
Shuhui Tan, Mingyue Liu, Fei Feng, Ruicheng Li, Rui Tian, Zhenhua Nie, Seth Agyei Domfeh. Exploring the pathogenesis and immunological profiles of psoriasis complicated with MASLD. PLOS ONE 2024; 19(6): e0305217 doi: 10.1371/journal.pone.0305217
|
15 |
Tao Hao, Hongying Chen, Sisi Wu, Haoming Tian. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10304
|
16 |
Cecilia Pessoa Rodrigues, Aindrila Chatterjee, Meike Wiese, Thomas Stehle, Witold Szymanski, Maria Shvedunova, Asifa Akhtar. Histone H4 lysine 16 acetylation controls central carbon metabolism and diet-induced obesity in mice. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26277-w
|
17 |
Kung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, Yu-De Chu, Chih-Lang Lin, Wey-Ran Lin, Ya-Hui Huang, Tong-Hung Wang, Rong-Nan Chien, Tsung-Hui Hu, Chau-Ting Yeh. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01761-1
|
18 |
Tiziano Balzano, Jerónimo Forteza, Pilar Molina, Juan Giner, Ana Monzó, Jennifer Sancho-Jiménez, Amparo Urios, Carmina Montoliu, Vicente Felipo. The Cerebellum of Patients with Steatohepatitis Shows Lymphocyte Infiltration, Microglial Activation and Loss of Purkinje and Granular Neurons. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21399-6
|
19 |
Bahram Namjou, Todd Lingren, Yongbo Huang, Sreeja Parameswaran, Beth L. Cobb, Ian B. Stanaway, John J. Connolly, Frank D. Mentch, Barbara Benoit, Xinnan Niu, Wei-Qi Wei, Robert J. Carroll, Jennifer A. Pacheco, Isaac T. W. Harley, Senad Divanovic, David S. Carrell, Eric B. Larson, David J. Carey, Shefali Verma, Marylyn D. Ritchie, Ali G. Gharavi, Shawn Murphy, Marc S. Williams, David R. Crosslin, Gail P. Jarvik, Iftikhar J. Kullo, Hakon Hakonarson, Rongling Li, Stavra A. Xanthakos, John B. Harley. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. BMC Medicine 2019; 17(1) doi: 10.1186/s12916-019-1364-z
|
20 |
George Papadopoulos, Robert Berland, Ashwini Sunkavalli, Stephen R. Coats, Richard P. Darveau, Caroline A. Genco, Marvin Whiteley. Microbial Lipid A Remodeling Controls Cross-Presentation Efficiency and CD8 T Cell Priming by Modulating Dendritic Cell Function. Infection and Immunity 2021; 89(2) doi: 10.1128/IAI.00335-20
|
21 |
Carlo Smirne, Violante Mulas, Matteo Nazzareno Barbaglia, Venkata Ramana Mallela, Rosalba Minisini, Nadia Barizzone, Michela Emma Burlone, Mario Pirisi, Elena Grossini. Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease. Diagnostics 2020; 10(12): 1003 doi: 10.3390/diagnostics10121003
|
22 |
Kirsten I M Looman, Susana Santos, Henriette A Moll, Charlotte W E Leijten, Christina Grosserichter-Wagener, Trudy Voortman, Vincent V W Jaddoe, Menno C van Zelm, Jessica C Kiefte-de Jong. Childhood Adiposity Associated With Expanded Effector Memory CD8+ and Vδ2+Vγ9+ T Cells. The Journal of Clinical Endocrinology & Metabolism 2021; 106(10): e3923 doi: 10.1210/clinem/dgab433
|
23 |
Anzhu Wang, Zhendong Li, Zhuo Sun, Yifei Wang, Shuangqing Fu, Dawu Zhang, Xiaochang Ma. Heart failure with preserved ejection fraction and non‐alcoholic fatty liver disease: new insights from bioinformatics. ESC Heart Failure 2023; 10(1): 416 doi: 10.1002/ehf2.14211
|
24 |
E. L. Nasonov, T. V. Korotaeva, T. V. Dubinina, A. M. Lila. IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS. Rheumatology Science and Practice 2019; 57(4): 400 doi: 10.14412/1995-4484-2019-400-406
|
25 |
Jeffrey B. Schwimmer, Jethro S. Johnson, Jorge E. Angeles, Cynthia Behling, Patricia H. Belt, Ingrid Borecki, Craig Bross, Janis Durelle, Nidhi P. Goyal, Gavin Hamilton, Mary L. Holtz, Joel E. Lavine, Makedonka Mitreva, Kimberly P. Newton, Amy Pan, Pippa M. Simpson, Claude B. Sirlin, Erica Sodergren, Rahul Tyagi, Katherine P. Yates, George M. Weinstock, Nita H. Salzman. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019; 157(4): 1109 doi: 10.1053/j.gastro.2019.06.028
|
26 |
E González-Reimers, C Martín-González, G Quintero-Platt, L Romero-Acevedo, O Pérez-Hernández. Relative and combined Effects of Ethanol and Hepatitis C Virus Infection on Serum Interleukin-17 Levels. Archives of Hepatitis Research 2017; 3(1): 013 doi: 10.17352/ahr.000010
|
27 |
Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal-Gonzalez, Magalie Boucher, Dinesh Hirenallur-Shanthappa, Jeffrey Morin, Alan C. Opsahl, Sarah R. Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler. Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. Cellular and Molecular Gastroenterology and Hepatology 2020; 10(4): 829 doi: 10.1016/j.jcmgh.2020.06.001
|
28 |
Claire E. McQuitty, Roger Williams, Shilpa Chokshi, Luca Urbani. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.574276
|
29 |
Suling Zeng, Bernd Schnabl. Roles for the mycobiome in liver disease. Liver International 2022; 42(4): 729 doi: 10.1111/liv.15160
|
30 |
Wenjing Gou, Di Zhang, Lianyin Gao. Qingdu decoction can reduce LPS induced ACLF endotoxemia by regulating microRNA-34c/MAZ/TJs and microRNA-122a/Zonulin/EGFR signal pathway. Journal of Ethnopharmacology 2023; 302: 115922 doi: 10.1016/j.jep.2022.115922
|
31 |
Yan Jia, Fenmiao Zhong, Shuoyi Jiang, Qin Guo, Huanhuan Jin, Feixia Wang, Mengmeng Li, Ling Wang, Anping Chen, Feng Zhang, Jiangjuan Shao, Shizhong Zheng. Periostin in chronic liver diseases: Current research and future perspectives. Life Sciences 2019; 226: 91 doi: 10.1016/j.lfs.2019.04.021
|
32 |
M. Gulubova, M. Hadzhi, L. Hadzhiilieva, D. Chonov, M. M. Ignatova. Dendritic Cells and T Cell Subsets in the Development of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Acta Medica Bulgarica 2021; 48(3): 49 doi: 10.2478/amb-2021-0037
|
33 |
Branka Filipovic, Snezana Lukic, Dragana Mijac, Marija Marjanovic-Haljilji, Marko Vojnovic, Jelena Bogdanovic, Tijana Glisic, Natasa Filipovic, Jamal Al Kiswani, Aleksandra Djokovic, Suncica Kapor, Slobodan Kapor, Zoran Bukumiric, Ana Starcevic. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(24): 13219 doi: 10.3390/ijms222413219
|
34 |
Alessandra Fiorillo, Juan-José Gallego, Franc Casanova-Ferrer, Carla Giménez-Garzó, Amparo Urios, Maria-Pilar Ballester, Lucia Durbán, Maria-Pilar Rios, Javier Megías, Teresa San Miguel, Elena Kosenko, Desamparados Escudero-García, Salvador Benlloch, Vicente Felipo, Carmina Montoliu. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(12): 10407 doi: 10.3390/ijms241210407
|
35 |
Piero Portincasa, Mohamad Khalil, Annarita Graziani, Gema Frühbeck, Gyorgy Baffy, Gabriella Garruti, Agostino Di Ciaula, Leonilde Bonfrate. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?. European Journal of Internal Medicine 2024; 119: 13 doi: 10.1016/j.ejim.2023.10.002
|
36 |
Mohamed E. Shaker, Mohamed F. Hamed, Ahmed A. Shaaban. Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators. Saudi Pharmaceutical Journal 2022; 30(3): 291 doi: 10.1016/j.jsps.2022.01.007
|
37 |
Lichen Bao, Jun Yin, Wen Gao, Qun Wang, Wenbing Yao, Xiangdong Gao. A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway. British Journal of Pharmacology 2018; 175(16): 3379 doi: 10.1111/bph.14383
|
38 |
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Experimental and Molecular Pathology 2022; 124: 104733 doi: 10.1016/j.yexmp.2021.104733
|
39 |
Keisuke Sawada, Hak Chung, Samir Softic, Maria E. Moreno-Fernandez, Senad Divanovic. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism 2023; 35(11): 1852 doi: 10.1016/j.cmet.2023.10.009
|
40 |
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World Journal of Gastroenterology 2023; 29(32): 4831-4850 doi: 10.3748/wjg.v29.i32.4831
Abstract(579) |
Core Tip(636) |
Full Article(HTML)(5189)
|
Full Article with Cover (PDF)-7927K(143)
|
Full Article (Word)-2109K(65)
|
Audio-1055K(9)
|
Peer-Review Report-223K(86)
|
Answering Reviewers-111K(87)
|
Full Article (PDF)-7683K(356)
|
Full Article (XML)-377K(85)
|
Times Cited (19)
|
Total Visits (9320)
|
Open
|